Nucleating actin for invasion

The invasion of cancer cells into the surrounding tissue is a prerequisite and initial step in metastasis, which is the leading cause of death from cancer. Invasive cell migration requires the formation of various structures, such as invadopodia and pseudopodia, which require actin assembly that is regulated by specialized actin nucleation factors. There is a large variety of different actin nucleators in human cells, such as formins, spire and Arp2/3-regulating proteins, and the list is likely to grow. Studies of the mechanisms of various actin nucleation factors that are involved in cancer cell function may ultimately provide new treatments for invasive and metastatic disease.

[1]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[2]  S. Narumiya,et al.  mDia1 Targets v-Src to the Cell Periphery and Facilitates Cell Transformation, Tumorigenesis, and Invasion , 2010, Molecular and Cellular Biology.

[3]  E. Schuuring,et al.  Cortactin expression predicts poor survival in laryngeal carcinoma , 2008, British Journal of Cancer.

[4]  J. Zuchero,et al.  p53-cofactor JMY is a Multifunctional Actin Nucleation Factor , 2009, Nature Cell Biology.

[5]  M. Higashi,et al.  Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. , 2009, International journal of oncology.

[6]  J. Parsons,et al.  Identification and characterization of a novel cytoskeleton-associated pp60src substrate , 1991, Molecular and cellular biology.

[7]  A. Chhabra,et al.  Expression of the WASP Verprolin-Homologues (WAVE Members) in Human Breast Cancer , 2008, Oncology.

[8]  H. Higgs,et al.  Dia-Interacting Protein Modulates Formin-Mediated Actin Assembly at the Cell Cortex , 2007, Current Biology.

[9]  M. Mottolese,et al.  The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors , 2006, Clinical Cancer Research.

[10]  N. Smith,et al.  Sequential Interaction of Actin-related Proteins 2 and 3 (Arp2/3) Complex with Neural Wiscott-Aldrich Syndrome Protein (N-WASP) and Cortactin during Branched Actin Filament Network Formation* , 2003, Journal of Biological Chemistry.

[11]  N. Seki,et al.  Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy. , 2006, Investigative ophthalmology & visual science.

[12]  Guenter P. Resch,et al.  Clustering of VASP actively drives processive, WH2 domain‐mediated actin filament elongation , 2008, The EMBO journal.

[13]  Ming-cong Mo,et al.  VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer , 2010, Journal of surgical oncology.

[14]  M. Kirschner,et al.  Erk/Src Phosphorylation of Cortactin Acts as a Switch On-Switch Off Mechanism That Controls Its Ability To Activate N-WASP , 2004, Molecular and Cellular Biology.

[15]  M. Rubin,et al.  Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. , 2009, Cancer research.

[16]  Alfred Nordheim,et al.  Linking actin dynamics and gene transcription to drive cellular motile functions , 2010, Nature Reviews Molecular Cell Biology.

[17]  R. Grosse,et al.  Get to grips: steering local actin dynamics with IQGAPs , 2007, EMBO reports.

[18]  M. Fresno,et al.  Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas , 2009, The Journal of pathology.

[19]  M. Carlier,et al.  Regulation of actin assembly associated with protrusion and adhesion in cell migration. , 2008, Physiological reviews.

[20]  Niels Volkmann,et al.  The structural basis of actin filament branching by the Arp2/3 complex , 2008, The Journal of cell biology.

[21]  D. Lauffenburger,et al.  A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. , 2008, Developmental cell.

[22]  J. Ji,et al.  Dominant expression of 85-kDa form of cortactin in colorectal cancer , 2006, Journal of Cancer Research and Clinical Oncology.

[23]  S. Weed,et al.  Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression , 2010, Modern Pathology.

[24]  John S. Condeelis,et al.  Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.

[25]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[26]  Klemens Rottner,et al.  Arp2/3 complex interactions and actin network turnover in lamellipodia , 2008, The EMBO journal.

[27]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[28]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[29]  P. Timpson,et al.  Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. , 2007, Cancer research.

[30]  T. Nagao,et al.  Correlation between liver metastasis of the colocalization of actin‐related protein 2 and 3 complex and WAVE2 in colorectal carcinoma , 2007, Cancer science.

[31]  Guenter P. Resch,et al.  Electron tomography reveals unbranched networks of actin filaments in lamellipodia , 2010, Nature Cell Biology.

[32]  O. Pertz,et al.  Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC , 2010, Oncogene.

[33]  S. Weed,et al.  Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. , 2006, Cancer research.

[34]  W. Kabsch,et al.  Atomic model of the actin filament , 1990, Nature.

[35]  A. Kallioniemi,et al.  Characterization of the 7q21‐q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer , 2009, Genes, chromosomes & cancer.

[36]  C. Haudenschild,et al.  Cortactin potentiates bone metastasis of breast cancer cells. , 2001, Cancer research.

[37]  Françoise Seillier-Moiseiwitsch,et al.  Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. , 2006, Cancer research.

[38]  T D Pollard,et al.  The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. L. La Thangue,et al.  A transcription co-factor integrates cell adhesion and motility with the p53 response , 2009, Proceedings of the National Academy of Sciences.

[40]  M. Gardel,et al.  Identification and characterization of a small molecule inhibitor of formin-mediated actin assembly. , 2009, Chemistry & biology.

[41]  N. den Elzen,et al.  Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts. , 2005, Molecular biology of the cell.

[42]  Petra Beli,et al.  WAVE and Arp2/3 jointly inhibit filopodium formation by entering into a complex with mDia2 , 2008, Nature Cell Biology.

[43]  Tsutomu Ohta,et al.  Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. , 2004, Journal of hepatology.

[44]  C. Marshall,et al.  DOCK10-Mediated Cdc42 Activation Is Necessary for Amoeboid Invasion of Melanoma Cells , 2008, Current Biology.

[45]  Erik Sahai,et al.  Myocardin-Related Transcription Factors and SRF are required for cytoskeletal dynamics, invasion and experimental metastasis , 2009, Nature Cell Biology.

[46]  H. Higgs,et al.  Phylogenetic analysis of the formin homology 2 domain. , 2004, Molecular biology of the cell.

[47]  E. Kremmer,et al.  Formin-like 1 (FMNL1) Is Regulated by N-terminal Myristoylation and Induces Polarized Membrane Blebbing* , 2009, The Journal of Biological Chemistry.

[48]  H. Fernando,et al.  WAVE1 is associated with invasiveness and growth of prostate cancer cells. , 2008, The Journal of urology.

[49]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[50]  Jean Jakoncic,et al.  Migrastatin analogues target fascin to block tumour metastasis , 2011, Nature.

[51]  Gordon B Mills,et al.  Lysophosphatidic acid (LPA)‐induced vasodilator‐stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC‐3 prostate cancer cells , 2008, Molecular oncology.

[52]  S. Nieh,et al.  Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness , 2009, World Journal of Urology.

[53]  Matthew D. Welch,et al.  A nucleator arms race: cellular control of actin assembly , 2010, Nature Reviews Molecular Cell Biology.

[54]  Chunsheng Zhang,et al.  Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers , 2010, Proceedings of the National Academy of Sciences.

[55]  Jacco van Rheenen,et al.  Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation , 2009, The Journal of cell biology.

[56]  B. Goode,et al.  Actin nucleation and elongation factors: mechanisms and interplay. , 2009, Current opinion in cell biology.

[57]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[58]  C. Marshall,et al.  The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. , 2010, Current opinion in cell biology.

[59]  D. Chan,et al.  Association of Cortactin and Fascin-1 Expression in Gastric Adenocarcinoma: Correlation With Clinicopathological Parameters , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[60]  M. Eck,et al.  Mechanism and function of formins in the control of actin assembly. , 2007, Annual review of biochemistry.

[61]  J. Grosshans,et al.  Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. , 2007, Genes & development.

[62]  E. Kremmer,et al.  SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of β1-integrin , 2009, Nature Cell Biology.

[63]  Shiro Suetsugu,et al.  Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells , 2005, Oncogene.

[64]  J. Zavadil,et al.  Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.

[65]  T. Pollard,et al.  Characterization of two classes of small molecule inhibitors of Arp2/3 complex , 2009, Nature.

[66]  P. Friedl,et al.  Plasticity of cell migration: a multiscale tuning model , 2010 .

[67]  J. Vandekerckhove,et al.  cAMP-dependent Protein Kinase Phosphorylation of EVL, a Mena/VASP Relative, Regulates Its Interaction with Actin and SH3 Domains* , 2000, The Journal of Biological Chemistry.

[68]  Yanqing Ding,et al.  Overexpression of FMNL2 is closely related to metastasis of colorectal cancer , 2008, International Journal of Colorectal Disease.

[69]  J. Condeelis,et al.  Imaging Sites of N-WASP Activity in Lamellipodia and Invadopodia of Carcinoma Cells , 2004, Current Biology.

[70]  Alissa M. Weaver,et al.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon , 2008, Oncogene.

[71]  J. Segall,et al.  Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. , 2007, Cancer research.

[72]  D. Yamazaki,et al.  Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. , 2009, Oncogene.

[73]  Kiyoshi Mukai,et al.  Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma , 2007, Modern Pathology.

[74]  P. Gounon,et al.  The Arp2/3 complex branches filament barbed ends: functional antagonism with capping proteins , 2000, Nature Cell Biology.

[75]  H. Katayama,et al.  Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A , 2010, The Journal of cell biology.

[76]  J. Forbes,et al.  EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival , 1998, Oncogene.

[77]  D. Horsfall,et al.  EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer , 1997, Oncogene.

[78]  O. Fackler,et al.  Cell motility through plasma membrane blebbing , 2008, The Journal of cell biology.

[79]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[80]  K. Eisenmann,et al.  The role of formins in human disease. , 2010, Biochimica et biophysica acta.

[81]  James Moseley,et al.  An actin nucleation mechanism mediated by Bni1 and Profilin , 2002, Nature Cell Biology.

[82]  R. Zhao,et al.  Expression of Cortactin Correlates with a Poor Prognosis in Patients with Stages II–III Colorectal Adenocarcinoma , 2010, Journal of Gastrointestinal Surgery.

[83]  A. Mizuno,et al.  Overexpression of Cortactin Increases Invasion Potential in Oral Squamous Cell Carcinoma , 2010, Pathology & Oncology Research.

[84]  E. Schuuring,et al.  Markers for assessment of nodal metastasis in laryngeal carcinoma. , 1997, Archives of otolaryngology--head & neck surgery.

[85]  H. Su,et al.  Association of Cortactin, Fascin-1 and Epidermal Growth Factor Receptor (EGFR) Expression in Ovarian Carcinomas: Correlation with Clinicopathological Parameters , 2008, Disease markers.

[86]  Zhong-ying Shen,et al.  The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. , 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[87]  K. Siminovitch,et al.  The mDial Formin Is Required for Neutrophil Polarization, Migration, and Activation of the LARG/RhoA/ROCK Signaling Axis during Chemotaxis1 , 2009, The Journal of Immunology.

[88]  G. M. Di Guglielmo,et al.  Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization* , 2010, The Journal of Biological Chemistry.

[89]  J. Condeelis,et al.  N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. , 2009, Cell motility and the cytoskeleton.

[90]  Nicole S. Bryce,et al.  Cortactin Promotes Cell Motility by Enhancing Lamellipodial Persistence , 2005, Current Biology.

[91]  J. R. Peterson,et al.  Isoform-selective chemical inhibition of mDia-mediated actin assembly. , 2009, Biochemistry.

[92]  T. Takenawa,et al.  Focal Adhesion Kinase Regulation of N-WASP Subcellular Localization and Function* , 2004, Journal of Biological Chemistry.

[93]  Anne J. Ridley,et al.  Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.

[94]  仙波 征太郎.  Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung , 2006 .

[95]  John G. Collard,et al.  Rho GTPases: functions and association with cancer , 2007, Clinical & Experimental Metastasis.

[96]  P. Brousset,et al.  High expression of FMNL1 protein in T non-Hodgkin's lymphomas. , 2006, Leukemia research.

[97]  N. Guevara,et al.  Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status , 2008, British Journal of Cancer.

[98]  H. Fernando,et al.  WAVE3 is associated with invasiveness in prostate cancer cells. , 2010, Urologic oncology.

[99]  Elaine Fuchs,et al.  Cyfip1 Is a Putative Invasion Suppressor in Epithelial Cancers , 2009, Cell.

[100]  Sheila M. Thomas,et al.  Cortactin regulates cell migration through activation of N-WASP , 2005, Journal of Cell Science.

[101]  John Condeelis,et al.  The cofilin pathway in breast cancer invasion and metastasis , 2007, Nature Reviews Cancer.

[102]  Monilola A. Olayioye,et al.  Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. , 2008, Cancer research.

[103]  J. Guan,et al.  Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners , 2006, Nature Cell Biology.

[104]  J. Downward,et al.  Roles of cortactin in tumor pathogenesis. , 2007, Biochimica et biophysica acta.

[105]  D. Sept,et al.  An actin-filament-binding interface on the Arp2/3 complex is critical for nucleation and branch stability , 2010, Proceedings of the National Academy of Sciences.

[106]  Marie-France Carlier,et al.  Control of actin filament treadmilling in cell motility. , 2010, Annual review of biophysics.

[107]  Fan Wu,et al.  Increased Expression of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein 2 Correlated with Poor Prognosis of Hepatocellular Carcinoma , 2006, Clinical Cancer Research.

[108]  E. Sahai,et al.  Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.

[109]  K. Cao,et al.  EVL (Ena/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages. , 2008, Oncology reports.

[110]  T. Takenawa,et al.  Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. , 2002, Cancer research.

[111]  Gary G. Borisy,et al.  Antagonism between Ena/VASP Proteins and Actin Filament Capping Regulates Fibroblast Motility , 2002, Cell.

[112]  Thomas D. Pollard,et al.  Actin, a Central Player in Cell Shape and Movement , 2009, Science.

[113]  T. Tsunoda,et al.  Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. , 2001, Neoplasia.

[114]  J. Condeelis,et al.  WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cells , 2008, The Journal of cell biology.

[115]  C. Tzao,et al.  Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[116]  L. Bourguignon,et al.  Hyaluronan-CD44 Interaction with Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promotes Actin Polymerization and ErbB2 Activation Leading to β-Catenin Nuclear Translocation, Transcriptional Up-regulation, and Cell Migration in Ovarian Tumor Cells* , 2007, Journal of Biological Chemistry.

[117]  C. D. dos Remedios,et al.  Actin binding proteins: regulation of cytoskeletal microfilaments. , 2003, Physiological reviews.

[118]  M. Kirschner,et al.  Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation , 2004, Nature Structural &Molecular Biology.

[119]  大坪 十四哉.  Involvement of Arp2/3 complex in the process of colorectal carcinogenesis , 2004 .

[120]  A. Luini,et al.  Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation , 2008, Journal of Cell Science.

[121]  Andrei V Bakin,et al.  Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. , 2007, The American journal of pathology.

[122]  S. Nieh,et al.  Expression of Survivin and Cortactin in Colorectal Adenocarcinoma: Association with Clinicopathological Parameters , 2009, Disease markers.

[123]  Lin Chen,et al.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[124]  E. Schuuring,et al.  Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. , 1996, Oncogene.

[125]  Hai-long Xie,et al.  Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis , 2010, Journal of digestive diseases.

[126]  Frank B. Gertler,et al.  Ena/VASP: towards resolving a pointed controversy at the barbed end , 2009, Journal of Cell Science.

[127]  D. Busch,et al.  Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. , 2007, Blood.

[128]  G. Pula,et al.  Role of Ena/VASP proteins in homeostasis and disease. , 2008, Handbook of experimental pharmacology.

[129]  Alissa M. Weaver.  Cortactin in tumor invasiveness. , 2008, Cancer letters.

[130]  K. Sossey-Alaoui,et al.  The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion* , 2009, The Journal of Biological Chemistry.

[131]  Charles Boone,et al.  Role of Formins in Actin Assembly: Nucleation and Barbed-End Association , 2002, Science.

[132]  Guillem Rigaill,et al.  Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells. , 2009, Cancer research.

[133]  D. Kovar.  Molecular details of formin-mediated actin assembly. , 2006, Current opinion in cell biology.

[134]  S. Narumiya,et al.  Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion , 2009, Cancer and Metastasis Reviews.

[135]  Alissa M. Weaver,et al.  Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. , 2007, Cancer research.

[136]  Jason V. Evans,et al.  Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function. , 2009, Journal of cancer science & therapy.

[137]  R. Treisman,et al.  A role for VASP in RhoA‐Diaphanous signalling to actin dynamics and SRF activity , 2003, The EMBO journal.

[138]  R. Grosse,et al.  SnapShot: Formins , 2010, Cell.

[139]  Susumu Mori,et al.  Filopodia are required for cortical neurite initiation , 2007, Nature Cell Biology.

[140]  Q. Zhan,et al.  Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. , 2006, Cancer research.

[141]  S. Benichou,et al.  The Diaphanous-related Formin FHOD1 Associates with ROCK1 and Promotes Src-dependent Plasma Membrane Blebbing* , 2008, Journal of Biological Chemistry.

[142]  S. Weed,et al.  Src phosphorylation of cortactin enhances actin assembly , 2007, Proceedings of the National Academy of Sciences.

[143]  Y. Takano,et al.  Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. , 2008, International journal of oncology.

[144]  Stephen J. Weiss,et al.  Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited , 2009, The Journal of cell biology.

[145]  U. Kayisli,et al.  Differential expression of VASP in normal lung tissue and lung adenocarcinomas , 2005, Thorax.

[146]  F. Modugno,et al.  Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo , 2008, Clinical & Experimental Metastasis.

[147]  S. Snapper,et al.  Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice. , 2010, The Journal of clinical investigation.

[148]  J. Uhm.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .

[149]  James E Bear,et al.  Negative Regulation of Fibroblast Motility by Ena/VASP Proteins , 2000, Cell.

[150]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[151]  G. Watkins,et al.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer , 2007, Clinical & Experimental Metastasis.

[152]  Andrei V Bakin,et al.  WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. , 2005, Experimental cell research.

[153]  Guillaume Charras,et al.  Blebs lead the way: how to migrate without lamellipodia , 2008, Nature Reviews Molecular Cell Biology.